Patents by Inventor Maurice Mannesse

Maurice Mannesse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
    Patent number: 9211318
    Abstract: The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: December 15, 2015
    Assignee: PHARMING INTELLECTUAL PROPERTY B.V.
    Inventors: Maurice Mannesse, Johannes Henricus Nuijens, Frank Pieper, Maria Grazia De Simoni, Gijsbertus Johannes Ziere
  • Use Of C1 Inhibitor For The Prevention Of Ischemia-Reperfusion Injury
    Publication number: 20130244941
    Abstract: The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.
    Type: Application
    Filed: February 25, 2013
    Publication date: September 19, 2013
    Applicant: PHARMING INTELLECTUAL PROPERTY B.V.
    Inventors: Maurice Mannesse, Johannes Henricus Nuijens, Frank Pieper, Maria Grazia De Simoni, Gijsbertus Johannes Ziere
  • Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
    Patent number: 8415288
    Abstract: The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.
    Type: Grant
    Filed: October 11, 2011
    Date of Patent: April 9, 2013
    Assignee: Pharming Intellectual Property B.V.
    Inventors: Maurice Mannesse, Johannes Henricus Nuijens, Frank Pieper, Maria Grazia De Simoni, Gijsbertus Johannes Ziere
  • USE OF C1 INHIBITOR FOR THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY
    Publication number: 20120088728
    Abstract: The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.
    Type: Application
    Filed: October 11, 2011
    Publication date: April 12, 2012
    Applicant: PHARMING INTELLECTUAL PROPERTY B.V.
    Inventors: Maurice Mannesse, Johannes Henricus Nuijens, Frank Pieper, Maria Grazia De Simoni, Gijsbertus Johannes Ziere
  • Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
    Patent number: 8071532
    Abstract: The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: December 6, 2011
    Assignee: Pharming Intellectual Property B.V.
    Inventors: Maurice Mannesse, Johannes Henricus Nuijens, Frank Pieper, Maria Grazia De Simoni, Gijsbertus Johannes Ziere
  • Use of C1 Inhibitor for the Prevention of Ischemia-Reperfusion Injury
    Publication number: 20080305993
    Abstract: The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.
    Type: Application
    Filed: December 19, 2006
    Publication date: December 11, 2008
    Applicant: Pharming Intellectual Property B.V.
    Inventors: Maurice Mannesse, Johannes Henricus Nuijens, Frank Pieper, Maria Grazia De Simoni, Gijsbertus Johannes Ziere
  • Protein modification
    Publication number: 20060142220
    Abstract: The present invention relates to a method for changing the half-life of a glycosylated compound by the modification of its O-linked carbohydrates. This modification is preferably carried out enzymatically and aimed at extending the half-life of the compound. Both in vivo and in vitro modification protocols may be used.
    Type: Application
    Filed: October 17, 2003
    Publication date: June 29, 2006
    Inventors: Patrick Berkel, Maurice Mannesse, Frank Pieper